Enzo BiochemENZ
Market Cap: $57.6M
About: Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Employees: 190
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
0% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]
3.06% less ownership
Funds ownership: 27.12% [Q1] → 24.06% (-3.06%) [Q2]
5% less funds holding
Funds holding: 41 [Q1] → 39 (-2) [Q2]
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
24% less capital invested
Capital invested by funds: $17.6M [Q1] → $13.5M (-$4.15M) [Q2]
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Research analyst outlook
We haven’t received any recent analyst ratings for ENZ.